Adjuvant sorafenib after heptectomy for Barcelona Clinic Liver Cancer-stage C hepatocellular carcinoma patients

Table 2 Surgical outcomes

Variable	Sorafenib	Control	P value2
Type of resection			-
Minor	8	16
Major3	26	52
Intraoperative blood loss, mL1	350 (50-1600)	380 (50-1800)	0.132
Intraoperative blood transfusion, mL1	650 (0-1500)	600 (0-1600)	0.126
No. of patients without transfusion, %	31 (75.0%)	58 (81.48%)	0.139
Postoperative AST on day 3, IU/L1	226 (48-896)	327 (68-1237)	0.042
Postoperative total bilirubin on day 3, mmol/L1	42 (19-276)	39 (18-212)	0.138
Infectious morbidity	8	12	0.566
Lung infection	3	4
Abdominal collection	4	6
Infection of incisional wound	1	1
Sepsis	0	1
Noninfectious morbidity	4	9	0.853
Pleural effusion	3	5
Bile leak	1	4
Liver failure	0	0

¹Value expressed in median with range in parentheses;

²Study group compared with control group;

³Major hepatectomy was defined as resection of three or more segments.